Shares of Gilead Sciences Inc. GILD inched 0.06% higher to $83.99 Monday, on what proved to be an all-around great trading ...
Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.
Gilead Sciences Inc. closed $3.98 short of its 52-week high ($87.87), which the company achieved on January 19th.
IBBQ is a relatively new US biotech ETF that competes with established peers like IBB and XBI. Read why I don't recommend ...
Today, Benzinga's options scanner spotted 9 options trades for Gilead Sciences. This is not a typical pattern. The sentiment ...
Gilead Sciences (GILD) stock price has staged a strong comeback this year, helped by strong earnings and a recent $40 million ...
In the latest supply deal on the active pharmaceutical ingredients (API) front, Gilead Sciences has tapped South Korea’s ...
The Healthy on MSN7h
A COVID Medication Has Been Recalled NationwideThe manufacturer says the drug is indicated for the treatment of Covid-19 in adults and children, but an unexpected presence ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is issuing a voluntary recall of one lot of Veklury® (remdesivir) for Injection 100 mg/vial, to the consumer level. Gilead received a customer c ...
AstraZeneca and Daiichi Sankyo’s TROP2-directed antibody-drug conjugate (ADC) has again failed to improve overall survival ...
Zacks.com on MSN6d
Gilead Sciences (GILD) Stock Sinks As Market Gains: Here's WhyThe latest trading day saw Gilead Sciences (GILD) settling at $83.08, representing a -0.1% change from its previous close.
Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback